Kidney Week

Clinical Practice Session

Therapeutic Decisions in Glomerular Diseases: Updating the Algorithms

October 25, 2024 | 10:30 AM - 12:30 PM

Location: Room 6A, Convention Center

Session Description

Therapeutic decision-making in glomerular diseases is often based on less-than-adequate data and comes with high costs and risk of adverse effects. This session reviews these challenging therapeutic decisions and provides insights from experts.

Learning Objective(s)

• Summarize current evidence for use of avacopan, plasmapheresis, and rituximab in ANCA-associated vasculitis
• Describe the current therapeutic options for maintenance therapy in lupus nephritis
• Explain appropriate use of endothelin receptor antagonists, targeted-release formulation budesonide, and SGLT2 inhibitors in the management of IgAN
• Discuss alternatives to corticosteroids and their application in management of minimal change disease

Learning Pathway(s)

• Glomerular Diseases

Moderators

• Annette Bruchfeld, MD, PhD
• Ali Mehdi, MD, MEd, FASN

Presentations

• Management of Acute ANCA-Associated Glomerulonephritis: Evidence and Uncertainties
  10:30 AM - 11:00 AM
  
  • Duvuru Geetha, MD, FASN

Management of Acute ANCA-Associated Glomerulonephritis: Evidence and Uncertainties

October 25, 2024 | 10:30 AM - 11:00 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Approach to Maintenance Therapy in Lupus Nephritis
  11:00 AM - 11:30 AM
  
  • Samir V. Parikh, MD, FASN

Approach to Maintenance Therapy in Lupus Nephritis

October 25, 2024 | 11:00 AM - 11:30 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Use of SGLT2 Inhibitors, Endothelin Receptor Antagonists, and Targeted-Release Formulation Budesonide in IgAN
  11:30 AM - 12:00 PM
  
  • Pietro A. Canetta, MD, MS

Use of SGLT2 Inhibitors, Endothelin Receptor Antagonists, and Targeted-Release Formulation Budesonide in IgAN

October 25, 2024 | 11:30 AM - 12:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Treatment of Minimal Change Disease: Beyond Corticosteroids
  12:00 PM - 12:30 PM
  
  • Ladan Zand, MD

Treatment of Minimal Change Disease: Beyond Corticosteroids

October 25, 2024 | 12:00 PM - 12:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.